Trade Mark Journal No.2024/030 26 July 2024

WO0000001798869 (5)

Office of origin: United States of America

Date of International Registration:13 June 2024
Date of designation in the UK: 13 June 2024
Image for mark 1798869 SURGENEX

International priority date claimed: 14 December 2023 (United States of America) (98314133)
Class 5
Human allograft tissue.

Surgenex Holdings, LLC

Representative: Paul C. Llewellyn ARNOLD & PORTER KAYE SCHOLER LLP, 250 West 55th Street, New York NY 10019-9710, UNITED STATES OF AMERICA